Tag: entrepreneurs
-
CEPI Assessing Advanced RNA Nanoparticle Vaccine
An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics.
-
Audio Digital Biomarkers Start-Up Raises $3.7M in Seed Funds
A new company developing techniques to analyze internal physiological sounds captured by stethoscopes as health indicators is raising $3.7 million in seed funds.
-
Infographic – Mixed Signals on 2022 Venture Funding
Total venture funds invested fell each quarter in 2022, from $163.1 billion in Q1 to $77.2 billion in Q4, which suggests continued declines into 2023.
-
Skills That Help When Starting a Business
There are plenty of businesses that set up great products, yet fail because the owners weren’t great at decision-making or properly marketing what they’ve got.
-
Protein Chemistry Biotech Gains Collaboration, Venture Funds
An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech.
-
Company Started for Gene Editing Rare Inherited Diseases
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells.
-
Infographic – Cancer Start-Up Venture Funds Decline
Funding for new enterprises creating products and services that treat or detect cancer fell more than 40 percent from last year.
-
Food Protein Biotech Adds €4M in Seed Funds
A new company creating protein ingredients for food products from carbon dioxide converted by engineered bacteria is raising €4 million more in seed funds.
-
Immune Organoid Company Raises $4.3M in Seed Funds
A new company developing 3-D cell and tissue models of lymph nodes for discovery of immunotherapies is raising $4.3 million in seed funds.
-
Personal Allergy Start-Up Gains $16.5M in Early Funds
A new business that provides personalized allergy testing, drug making, and delivery to consumers is raising $16.5 million in its first venture funding round.